301065.SHE Zhejiang Benli Technology Co. Ltd.
- Market cap
- CNY 1.82B
- P/E
- 21.7x
- P/B
- 1.27x
- ROE
- 5.5%
- Dividend yield
- 1.14%
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.
Is 301065.SHE undervalued?
Graham number301065.SHE trades 10.7% above its Graham number.
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Zhejiang Benli Technology Co. Ltd. fundamental analysis
No fundamental analysis for Zhejiang Benli Technology Co. Ltd. yet.
Zhejiang Benli Technology Co. Ltd. stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Zhejiang Benli Technology Co. Ltd.
Zhejiang Benli Technology Co., Ltd. engages in the research, development, production, and sales of pharmaceutical, pesticide, and new material intermediates in China and internationally. Its products include 2,4-Dichloro-5-fluorobenzoyl chloride, 2-(2,4-Dichloro-5-fluorobenzoyl)-3-cyclopropylamine ethyl acrylate, 1-Ethyl-7-(1-piperazinyl) -6-fluoro-1, 4-dihydro-4-oxo-3-quinolinecarboxylic acid hydrochloride, 2,4-Dichlorofluorobenzene, and Methyl 3-methoxyacrylate; and Ethyl …
Full company profileZhejiang Benli Technology Co. Ltd. financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 3 quarters up to Sep 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
Zhejiang Benli Technology Co. Ltd. annual financial statements (CNY; K = thousand, M = million, B = billion, T = trillion)
| Item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | 559M | 625M | 621M | 759M | 698M | 709M | 639M | 672M |
| Gross Profit | 125M | 154M | 103M | 108M | 119M | 121M | 146M | 170M |
| Operating Income | 83.5M | 107M | 57.7M | 51.6M | 56.3M | 62.1M | 78.3M | 90.3M |
| EBITDA | 120M | 142M | 103M | 116M | 120M | 133M | 154M | 90.3M |
| Net Income | 73.1M | 91.7M | 54.8M | 59.8M | 59.6M | 64.6M | 78.8M | 78.6M |
| EPS | 1.38 | 1.15 | 0.52 | 0.56 | 0.56 | 0.61 | 0.74 | 0.74 |
| Balance Sheet | ||||||||
| Total Assets | 537M | 641M | 1.36B | 1.39B | 1.49B | 1.62B | 1.65B | 1.69B |
| Total Liabilities | 158M | 168M | 145M | 148M | 195M | 317M | 279M | 263M |
| Shareholders' Equity | 379M | 473M | 1.21B | 1.25B | 1.30B | 1.30B | 1.37B | 1.43B |
| Cash & Short-term Investments | 50.9M | 43.4M | 665M | 553M | 570M | 543M | 534M | 393M |
| Cash Flow | ||||||||
| Operating Cash Flow | 9.67M | 98.4M | 36.0M | 42.6M | 91.9M | 236M | 153M | - |
| Capital Expenditure | 51.1M | 90.0M | 50.0M | 131M | 64.0M | 105M | 112M | 248M |
| Free Cash Flow | -41.4M | 8.35M | -13.9M | -88.2M | 27.9M | 131M | 41.0M | -37.7M |
| Ratios | ||||||||
| ROE | 19.3% | 19.4% | 4.5% | 4.8% | 4.6% | 5.0% | 5.8% | 5.5% |
| ROA | 13.6% | 14.3% | 4.0% | 4.3% | 4.0% | 4.0% | 4.8% | 4.6% |
| Net Profit Margin | 13.1% | 14.7% | 8.8% | 7.9% | 8.5% | 9.1% | 12.3% | 11.7% |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
Zhejiang Benli Technology Co. Ltd. dividends
- Dividend yield
- 1.14%
- Forward dividend
- 0.30 CNY
- Payout ratio
- 26.2%
- Ex-dividend date
- Jun 16, 2026
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2025 | CNY 20.7M | 0.20 | 26.2% |
| 2024 | CNY 10.4M | 0.10 | 16.1% |
| 2023 | CNY 10.6M | 0.10 | 17.8% |
| 2022 | CNY 24.7M | 0.23 | 41.4% |
| 2021 | CNY 1.95M | 0.02 | 3.6% |
| 2020 | CNY 2.23M | 0.03 | 2.4% |
| 2019 | CNY 1.99M | 0.04 | 2.7% |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Last stock split: 1.5:1 on Jun 16, 2023.
Who owns Zhejiang Benli Technology Co. Ltd.
- Insiders 59.14%
- Institutions 1.57%
- Public & others 39.30%
- Shares outstanding 106M
- Free float 44.1M
Zhejiang Benli Technology Co. Ltd. company profile
- Company name
- Zhejiang Benli Technology Co. Ltd.
- Ticker
- 301065.SHE
- ISIN
- CNE100004RL8
- Exchange
- Shenzhen Stock Exchange
- Sector
- Basic Materials
- Industry
- Chemicals
- Employees
- 472
- Fiscal year end
- December
- Address
- No. 15 Donghai Sixth Avenue, Linhai, China, 317016
- Phone
- 86 57 6855 80770
- Website
- benlitech.com
About Zhejiang Benli Technology Co. Ltd.
Zhejiang Benli Technology Co., Ltd. engages in the research, development, production, and sales of pharmaceutical, pesticide, and new material intermediates in China and internationally. Its products include 2,4-Dichloro-5-fluorobenzoyl chloride, 2-(2,4-Dichloro-5-fluorobenzoyl)-3-cyclopropylamine ethyl acrylate, 1-Ethyl-7-(1-piperazinyl) -6-fluoro-1, 4-dihydro-4-oxo-3-quinolinecarboxylic acid hydrochloride, 2,4-Dichlorofluorobenzene, and Methyl 3-methoxyacrylate; and Ethyl N,N-dimethylaminoacrylate, 2,6-Dichlorofluorobenzene, and 3-(2-Ethylene Glycol Methyl Ether)-2-Methyl -4-Methanesulfonyl benzoic acid. The company was founded in 2011 and is based in Linhai, China.
Zhejiang Benli Technology Co. Ltd. management
4- Mr. Zhengjie WuChairman of the Board & GM · born 1964
- Mr. Chaoyang PanAccounting Supervisor, Deputy GM & CFO · born 1964
- Mr. Kaihong PanDeputy GM & Director · born 1979
- Ms. Jiajia WangDeputy GM & Board Secretary · born 1984